Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The possible relation of glutathione, melanin and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) to Parkinson's disease.

× No keyword cloud information.

9 in total

1. Modulation of [3H]dopamine release by glutathione in mouse striatal slices.

Authors: Réka Janáky; Róbert Dohovics; Pirjo Saransaari; Simo S Oja
Journal: Neurochem Res Date: 2007-03-31 Impact factor: 3.996

2. Pre-clinical therapeutic development of a series of metalloporphyrins for Parkinson's disease.

Authors: Li-Ping Liang; Jie Huang; Ruth Fulton; Jennifer N Pearson-Smith; Brian J Day; Manisha Patel
Journal: Toxicol Appl Pharmacol Date: 2017-04-08 Impact factor: 4.219

3. MPTP parkinsonism.

Authors: A Williams
Journal: Br Med J (Clin Res Ed) Date: 1984-11-24

4. Association Between Glutathione Peroxidase-1 (GPx-1) Polymorphisms and Schizophrenia in the Chinese Han Population.

Authors: Xiaojun Shao; Ci Yan; Dongxue Sun; Chunfeng Fu; Chunsheng Tian; Li Duan; Gang Zhu
Journal: Neuropsychiatr Dis Treat Date: 2020-10-06 Impact factor: 2.570

5. Neuroprotective effects of alpha-dihydroergocryptine against damages in the substantia nigra caused by severe treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Authors: G Bernocchi; G Gerzeli; E Scherini; C Vignola
Journal: Acta Neuropathol Date: 1993 Impact factor: 17.088

6. A disruption in iron-sulfur center biogenesis via inhibition of mitochondrial dithiol glutaredoxin 2 may contribute to mitochondrial and cellular iron dysregulation in mammalian glutathione-depleted dopaminergic cells: implications for Parkinson's disease.

Authors: Donna W Lee; Deepinder Kaur; Shankar J Chinta; Subramanian Rajagopalan; Julie K Andersen
Journal: Antioxid Redox Signal Date: 2009-09 Impact factor: 8.401

The possible relation of glutathione, melanin and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) to Parkinson's disease.

1. Modulation of [3H]dopamine release by glutathione in mouse striatal slices.

2. Pre-clinical therapeutic development of a series of metalloporphyrins for Parkinson's disease.

3. MPTP parkinsonism.

4. Association Between Glutathione Peroxidase-1 (GPx-1) Polymorphisms and Schizophrenia in the Chinese Han Population.

5. Neuroprotective effects of alpha-dihydroergocryptine against damages in the substantia nigra caused by severe treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

6. A disruption in iron-sulfur center biogenesis via inhibition of mitochondrial dithiol glutaredoxin 2 may contribute to mitochondrial and cellular iron dysregulation in mammalian glutathione-depleted dopaminergic cells: implications for Parkinson's disease.

7. Age-related effect induced by oxidative stress on the cerebral glutathione system.

8. Association between GPx-1 polymorphisms and personality traits in healthy Chinese-Han subjects.

Review 9. Glutathione in Brain Disorders and Aging.